Piper Sandler Companies

Piper Sandler Establishes Infrastructure Debt Advisory Team in London

Piper Sandler is establishing an infrastructure debt advisory team in London led by industry veteran Stewart Robinson, with Hugo Muller and Anish Shah hired as directors. The team joins from Nomura's debt advisory ranks and will sit within the firm's energy, power and infrastructure group, advising on debt financing and capital raising. The move broadens Piper Sandler's advisory offering across the capital structure, deepening its infrastructure franchise in EMEA.

•23d ago

Piper Sandler Launches Equities Trading in Europe with New Office Opening in Paris

Piper Sandler has launched equities trading in Europe and opened a new Paris office, backed by French regulatory approval and passporting rights across the EU. Ben Allen, head of sales and trading for Piper Sandler Europe, leads the new office. The firm hired senior equity salesperson Louis Renaudie and senior sales-trader Louis Carpentier from BNP Paribas and Edmond de Rothschild respectively, bringing the European expansion to a total of eight sales and trading hires following last year's Zurich office opening. President Deb Schoneman called the approval a significant milestone in the firm's global equities strategy, citing growing international demand for U.S. equity research that ranks top-10 in coverage universe and #1 in small and mid-cap liquidity per the 2025 Extel study.

•1mo ago

Piper Sandler Continues to Strengthen Private Capital Advisory with Addition of Tim Light as Managing Director of Secondary Capital Advisory

Piper Sandler appointed Tim Light as managing director of secondary capital advisory within its private capital advisory group. Light joins from Guggenheim with over a decade of experience advising private equity sponsors on secondary transactions and liquidity solutions. The hire strengthens the firm’s advisory platform amid growing demand for tailored secondary market strategies.

•2mo ago

PIPR: 10-Q · periodic report

Piper Sandler posted a strong second quarter of 2026, with U.S. GAAP net revenues of $495.5 million, up 24.9% year over year, and net income attributable to the company of $67.8 million, up 60.8%. Diluted EPS rose 61.0% to $0.95 ($1.04 adjusted), and pre-tax margin expanded to 20.3% from 12.3% a year ago. Investment banking drove the quarter, up 28.7% to $361.5 million, led by advisory services revenue of $274.2 million (+33.9%) on more completed M&A transactions and higher average fees, with strength in financial services, healthcare and middle-market depositories. Institutional brokerage slipped 2.6% to $111.5 million as a 13.8% decline in fixed income services offset 8.3% growth in equity brokerage, and investment income swung to $14.1 million from a $4.8 million loss. Capital returns stayed aggressive: the company paid $114.6 million of dividends in the first half (including a $1.25 per share special dividend tied to fiscal 2025 results), repurchased $63.6 million of stock with $58.0 million remaining authorized, and on July 30, 2026 declared a $0.20 per share quarterly dividend payable September 11, 2026. All share figures reflect a four-for-one forward stock split effective March 23, 2026. Cash and equivalents fell to $304.2 million from $809.4 million at year-end on bonus-season payouts, dividends and buybacks, while management kept a constructive but cautious outlook, flagging rate, tariff and geopolitical uncertainty and a seasonal Q3 decline in equity brokerage.

SEC 10-Q•2mo ago

Piper Sandler Companies Reports Second Quarter 2026 Results; Declares Quarterly Dividend of $0.20 Per Share

Piper Sandler Companies reported its second quarter 2026 financial results and declared a quarterly dividend of $0.20 per share. The release does not contain financial metrics but directs readers to the firm’s website for the complete earnings report. Management will host an earnings conference call on July 30, 2026, at 8:00 a.m. CT to discuss the quarter's performance.

•2mo ago

CereVasc, Inc. Announces Over-Subscribed $85 Million Series C Financing to Advance its Novel eShunt® System for the Treatment of Normal Pressure Hydrocephalus

CereVasc completed an $85 million Series C financing led by Piper Sandler Merchant Banking, with strategic participation from Johnson & Johnson Innovation and Medtronic. The capital will fund the conclusion of the STRIDE pivotal trial for its eShunt System, support regulatory work toward an FDA PMA submission, and prepare for US commercialization. The company also strengthened its board with the addition of Kevin Conroy as Lead Independent Director and Christopher Geyen as Audit Committee Chair.

•4mo ago

Piper Sandler Companies Reports First Quarter 2026 Results; Increases Quarterly Dividend to $0.20 Per Share

Piper Sandler Companies reported its first quarter 2026 financial results and announced an increase in its quarterly dividend to $0.20 per share. The company will host an earnings conference call on May 1, 2026, at 7:30 a.m. CT to discuss the results. The dividend increase reflects confidence in the firm's financial performance and capital generation capabilities.

•5mo ago

Piper Sandler Strengthens Healthcare Investment Banking Team with the Addition of Patrick McCormack

Piper Sandler hired Patrick McCormack, M.D., as a managing director in its healthcare investment banking group based in San Francisco. McCormack joins from Wells Fargo Securities and brings prior experience from Goldman Sachs, SVB Leerink, and SunTrust Robinson Humphrey, along with an MD and MBA. He will focus on advising biopharma clients on mergers and acquisitions as well as capital-raising transactions.

•5mo ago